Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Leonardo Azevedo Alvares"'
Autor:
Ana Carolina Costa Scerni, Leonardo Azevedo Alvares, Ana Cristina Beltrão, Iê Regina Bentes, Tereza Cristina Azevedo, Alessandra Quinto Bentes, José Alexandre Rodrigues Lemos
Publikováno v:
Clinics, Vol 64, Iss 8, Pp 731-734 (2009)
INTRODUCTION: In Brazil, patients with chronic myeloid leukemia (CML) in the chronic phase were not given first-line imatinib treatment until 2008. Therefore, there was a long period of time between diagnosis and the initiation of imatinib therapy fo
Externí odkaz:
https://doaj.org/article/99159d699f4e42ed9e834c7f5fa9a725
Autor:
Flávia Siqueira Cunha, Tania Aparecida Sartori Sanchez Bachega, Elaine Maria Frade Costa, Vinicius Nahime Brito, Leonardo Azevedo Alvares, Valéria Aparecida Costa-Hong, Renata Gomes Sanches Verardino, Maria Helena Palma Sircili, Berenice Bilharinho de Mendonça, Luiz Aparecido Bortolotto, Sorahia Domenice
Publikováno v:
Journal of the Endocrine Society. 7
Context The effects of androgen therapy on arterial function in transgender men (TM) are not fully understood, particularly concerning long-term androgen treatment. Objective To evaluate arterial stiffness in TM receiving long-term gender-affirming h
Autor:
José Alexandre Rodrigues de Lemos, Alessandra Quinto Bentes, Leonardo Azevedo Alvares, Tereza Cristina de Brito Azevedo, Ana Carolina Costa Scerni, Ana Cristina Simões Beltrão, Iê Regina Bentes
Publikováno v:
Clinics, Vol 64, Iss 8, Pp 731-734 (2009)
Clinics; v. 64 n. 8 (2009); 731-734
Clinics; Vol. 64 Núm. 8 (2009); 731-734
Clinics; Vol. 64 No. 8 (2009); 731-734
Clinics
Universidade de São Paulo (USP)
instacron:USP
Clinics (Sao Paulo, Brazil)
Repositório Institucional da UFPA
Universidade Federal do Pará (UFPA)
instacron:UFPA
Clinics, Volume: 64, Issue: 8, Pages: 731-734, Published: 2009
Clinics; v. 64 n. 8 (2009); 731-734
Clinics; Vol. 64 Núm. 8 (2009); 731-734
Clinics; Vol. 64 No. 8 (2009); 731-734
Clinics
Universidade de São Paulo (USP)
instacron:USP
Clinics (Sao Paulo, Brazil)
Repositório Institucional da UFPA
Universidade Federal do Pará (UFPA)
instacron:UFPA
Clinics, Volume: 64, Issue: 8, Pages: 731-734, Published: 2009
INTRODUCTION: In Brazil, patients with chronic myeloid leukemia (CML) in the chronic phase were not given first-line imatinib treatment until 2008. Therefore, there was a long period of time between diagnosis and the initiation of imatinib therapy fo